Turkish Version of the Pictorial Pain Interference Questionnaire
Not yet recruitingNCT07761208
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aims to culturally adapt the Pictorial Pain Interference Questionnaire into Turkish and evaluate its psychometric properties in individuals with chronic pain. The study will assess the validity and reliability of the Turkish version for evaluating the functional impact of chronic pain on daily life activities. Reliability will be examined through internal consistency and test-retest reliability, while validity will be assessed by examining the relationships between the questionnaire and established pain-related assessment tools. The study will determine whether the Turkish version provides a valid, reliable, and practical instrument for assessing functional interference associated with chronic pain in Turkish-speaking individuals.
Study details
- Official title
- Assessment of the Functional Impact of Chronic Pain: Psychometric Properties of the Turkish Version of the Pictorial Pain Interference Questionnaire
- Conditions
- Interventions
- Other: No Interventions
- Sponsor
- Istinye University
- Start date
- 2026-08-20
- Primary completion
- 2027-02-15
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Having chronic pain lasting for at least 3 months. * Willing to participate in the study and providing informed consent. * Having sufficient cognitive ability to understand the questions. Exclusion Criteria: * Severe cognitive impairment (e.g., dementia) or conditions that interfere with communication. * Inability to cooperate due to a psychiatric disorder. * Neurological or serious systemic diseases that may affect the assessment. * Incomplete or incorrectly completed questionnaires. * Refusal to participate or withdrawal from the study.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07761208